2. Signaling Pathways
  3. GPCR/G Protein
  4. Platelet-activating Factor Receptor (PAFR)

Platelet-activating Factor Receptor (PAFR)

The platelet-activating factor receptor (PAFR) is a G-protein-coupled receptor involved in both normal physiological and numerous pathophysiological processes. PAFR responds to platelet-activating factor (PAF), a phospholipid mediator of cell-to-cell communication that exhibits diverse physiological effects. Stimulation of the PAFR via binding of platelet-activating factor (PAF) elicits diverse and potent biological activities and plays a profound role in acute inflammation, allergic disorders, endotoxic shock, and anaphylaxis. PAF is a potent and versatile mediator of inflammation that is produced by numerous cell types and tissues, and particularly by leukocytes.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-113635
    ONO-6240
    		Antagonist
    ONO-6240 is a platelet-activating factor antagonist. ONO-6240 prevents EOS infiltration into airway. ONO-6240 can be used in the study of asthmatic.
    ONO-6240
  • HY-123397
    SCH-44643
    		Antagonist
    SCH-44643 is an orally active platelet activating factor (PAF) and histamine antagonist.
    SCH-44643
  • HY-N14934
    Aggreceride C
    		Inhibitor
    Aggreceride C is a platelet aggregation inhibitor. Aggreceride C shows an inhibitory activity against aggregation induced by Adenosine 5'-diphosphate (ADP) (HY-W010918), Arachidonic acid (HY-109590) and PAF (platelet activating factor), but was less active against aggregation induced by collagen.
    Aggreceride C
  • HY-100153
    48740 RP
    48740 RP ((Rac)-RP-55778) is a platelet-activating factor (PAF) antagonist.
    48740 RP
  • HY-U00040
    PAF-AN-1
    PAF-AN-1 is a platelet activating factor receptor (PAF) antagonist.
    PAF-AN-1
Cat. No. Product Name / Synonyms Application Reactivity